Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2022)